Hypersensitivity reactions associated with platinum antineoplastic agents: A systematic review

Metal-Based Drugs

Volumn 2010, Issue , 2010, Pages

  Makrilia, Nektaria ^a   Syrigou, Ekaterini ^a   Kaklamanos, Ioannis ^a   Manolopoulos, Leonidas ^a   Saif, Muhammad Wasif ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; BRONCHODILATING AGENT; CARBOPLATIN; CISPLATIN; CLEMASTINE; CORTICOSTEROID; DESLORATADINE; DEXAMETHASONE; DIPHENHYDRAMINE; FAMOTIDINE; FEXOFENADINE; HYDROCORTISONE; HYDROXYZINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INDOMETACIN; INTERLEUKIN 6; LORAZEPAM; MONTELUKAST; ONDANSETRON; OXALIPLATIN; PROMETHAZINE; RANITIDINE; SALBUTAMOL SULFATE; TUMOR NECROSIS FACTOR ALPHA; ZILEUTON;

ABDOMINAL CRAMP; AIRWAY OBSTRUCTION; ANAPHYLAXIS; ANTIGEN ANTIBODY COMPLEX; ARTHRALGIA; BACKACHE; BASOPHIL DEGRANULATION; BRONCHOSPASM; BURNING SENSATION; CANCER COMBINATION CHEMOTHERAPY; COMPLEMENT FIXATION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DESENSITIZATION; DIARRHEA; DRUG CYTOTOXICITY; DRUG ERUPTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; EOSINOPHIL; FACE EDEMA; HAND EDEMA; HEMOLYSIS; HOT FLUSH; HUMAN; HYPERSENSITIVITY REACTION; HYPERTENSION; HYPOTENSION; HYPOXEMIA; LARYNX SPASM; LOW DRUG DOSE; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MAST CELL DEGRANULATION; MULTIPLE CYCLE TREATMENT; NATURAL KILLER CELL; PATHOPHYSIOLOGY; PATIENT MONITORING; PHAGOCYTE; PREMEDICATION; PRIORITY JOURNAL; PROTEINURIA; PRURITUS; REVIEW; RISK FACTOR; SEIZURE; SKIN TEST; SYSTEMATIC REVIEW; TACHYCARDIA; TH1 CELL; TH2 CELL; THORAX PAIN; THROMBOCYTOPENIA; URTICARIA;

EID: 77957927866     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/207084     Document Type: Review

References (112)

1. Jamieson E. R., Lippard S. J., Structure, recognition, and processing of cisplatin-DNA adducts Chemical Reviews 1999 99 9 2467 2498
2. Charalabopoulos K., Karkabounas S., Ioachim E., Papalimneou V., Syrigos K., Evangelou A., Agnantis N., Hadjiliadis N., Antitumour and toxic effects on Wistar rats of two new platinum complexes European Journal of Clinical Investigation 2002 32 2 129 133
3. Covens A., Carey M., Bryson P., Verma S., Fung Kee Fung M., Johnston M., Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer Gynecologic Oncology 2002 85 1 71 80
4. Karapanagiotou E. M., Boura P. G., Papamichalis G., Konstantinou M., Sepsas E., Chamalakis G., Simsiris P., Gkiozos I., Syrigos K. N., Carboplatin-pemetrexed adjuvant chemotherapy in resected Non-small Cell Lung Cancer (NSCLC): a phase II study Anticancer Research 2009 29 10 4297 4301
5. Georgoulias V., Agelidou A., Syrigos K., Rapti A., Agelidou M., Nikolakopoulos J., Polyzos A., Athanasiadis A., Tselepatiotis E., Androulakis N., Kalbakis K., Samonis G., Mavroudis D., Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study British Journal of Cancer 2005 93 7 763 769
6. Georgoulias V., Ardavanis A., Tsiafaki X., Agelidou A., Mixalopoulou P., Anagnostopoulou O., Ziotopoulos P., Toubis M., Syrigos K., Samaras N., Polyzos A., Christou A., Kakolyris S., Kouroussis C., Androulakis N., Samonis G., Chatzidaki D., Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial Journal of Clinical Oncology 2005 23 13 2937 2945
7. Ignatiadis M., Mavroudis D., Veslemes M., Boukovinas J., Syrigos K., Agelidou M., Agelidou A., Gerogianni A., Pavlakou G., Tselepatiotis E., Nikolakopoulos J., Georgoulias V., Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a phase III trial of the hellenic oncology research group Clinical Lung Cancer 2005 7 3 183 189
8. Pectasides D., Samantas E., Fountzilas G., Briasoulis E., Kosmidis P., Skarlos D., Dimopoulos M. A., Kalofonos H. P., Economopoulos T., Syrigos K., Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: a phase II study of the Hellenic Co-operative Oncology Group Lung Cancer 2007 58 3 355 361
9. Charpidou A., Tsagouli S., Tsimpoukis S., Vassias A., Makrilia N., Stratakos G., Gkiozos I., Syrigos K., Triplet combination of carboplatin, irinotecan, and etoposide in the first-line treatment of extensive small-cell lung cancer: a single-institution phase II study Anti-Cancer Drugs 2010 21 6 651 655
10. Katirtzoglou N., Gkiozos I., Makrilia N., Tsaroucha E., Rapti A., Stratakos G., Fountzilas G., Syrigos K. N., Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: a phase II study Clinical Lung Cancer 2010 11 1 30 35
11. Androulakis N., Aravantinos G., Syrigos K., Polyzos A., Ziras N., Tselepatiotis E., Samonis G., Kentepozidis N., Giassas S., Vamvakas L., Georgoulias V., Oxaliplatin as first-line treatment in inoperable biliary tract carcinoma: a multicenter phase II study Oncology 2006 70 4 280 284
12. Ziras N., Potamianou A., Varthalitis I., Syrigos K., Tsousis S., Boukovinas I., Tselepatiotis E., Christofillakis C., Georgoulias V., Multicenter phase II study of gemcitabine and oxaliplatin (GEMOX) as second-line chemotherapy in colorectal cancer patients pretreated with 5-fluorouracil plus irinotecan Oncology 2006 70 2 106 114 (Pubitemid 43760336)
13. Androulakis N., Syrigos K., Polyzos A., Aravantinos G., Stathopoulos G. P., Ziras N., Mallas K., Vamvakas L., Georgoulis V., Oxaliplatin for pretreated patients with advanced or metastatic pancreatic cancer: a multicenter phase II study Cancer Investigation 2005 23 1 9 12
14. Polyzos A., Syrigos K., Stergiou J., Panopoulos C., Potamianou A., Vamvakas L., Georgoulias V., Phase I trial of weekly docetaxel with a 4-weekly cisplatin administration in patients with advanced gastric carcinoma Cancer Chemotherapy and Pharmacology 2005 55 5 466 470
15. Syrigos K. N., Karachalios D., Karapanagiotou E. M., Nutting C. M., Manolopoulos L., Harrington K. J., Head and neck cancer in the elderly: an overview on the treatment modalities Cancer Treatment Reviews 2009 35 3 237 245
16. Yu D. Y., Dahl G. V. H., Shames R. S., Fisher P. G., Weekly dosing of carboplatin increases risk of allergy in children Journal of Pediatric Hematology/Oncology 2001 23 6 349 352
17. Lafay-Cousin L., Sung L., Carret A.-S., Hukin J., Wilson B., Johnston D. L., Zelcer S., Silva M., Odame I., Mpotu C., Strother D., Bouffet E., Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a canadian pediatric brain tumor consortium experience Cancer 2008 112 4 892 899
18. Markman M., Kennedy A., Webster K., Kulp B., Peterson G., Belinson J., Continued chemosensitivity to cisplatin/carboplatin in ovarian carcinoma despite treatment with multiple prior platinum-based regimens Gynecologic Oncology 1997 65 3 434 436
19. Kakolyris S., Ziras N., Vamvakas L., Varthalitis J., Papakotoulas P., Syrigos K., Vardakis N., Kalykaki A., Amarantidis K., Georgoulias V., Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): a multicenter phase II study Lung Cancer 2006 54 3 347 352 (Pubitemid 44634148)
20. Ozols R. F., Bundy B. N., Greer B. E., Fowler J. M., Clarke-Pearson D., Burger R. A., Mannel R. S., DeGeest K., Hartenbach E. M., Baergen R., Mackey D., Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study Journal of Clinical Oncology 2003 21 17 3194 3200
21. Syrigos K. N., Vansteenkiste J., Parikh P., von Pawel J., Manegold C., Martins R. G., Simms L., Sugarman K. P., Visseren-Grul C., Scagliotti G. V., Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer Annals of Oncology 2010 21 3 556 561
22. Gkiozos I., Charpidou A., Syrigos K., Developments in the treatment of non-small cell lung cancer Anticancer Research 2007 27 4 C 2823 2827 (Pubitemid 47228004)
23. Souglakos J., Syrigos K., Potamianou A., Polyzos A., Boukovinas I., Androulakis N., Kouroussis CH., Vardakis N., Christophilakis CH., Kotsakis A., Georgoulias V., Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial Annals of Oncology 2004 15 8 1204 1209
24. Dimou A. T., Syrigos K. N., Saif M. W., Neuroendocrine tumors of the pancreas: what's new Journal of the Pancreas 2010 11 2 135 138. highlights from the "2010 ASCO Gastrointestinal Cancers Symposium"
25. Strimpakos A. S., Syrigos K. N., Saif M. W., Translational research in pancreatic cancer Journal of the Pancreas 2010 11 2 124 127. highlights from the "2010 ASCO Gastrointestinal Cancers Symposium"
26. Strimpakos A. S., Syrigos K. N., Saif M. W., Pharmacogenetics in pancreatic cancer. Highlights from the "45th ASCO Annual Meeting". Orlando, FL, USA. May 29-June 2, 2009 Journal of the Pancreas 2009 10 4 357 360
27. Strimpakos A., Saif M. W., Syrigos K. N., Pancreatic cancer: from molecular pathogenesis to targeted therapy Cancer and Metastasis Reviews 2008 27 3 495 522
28. Syrigos K. N., Sitara D., Georgiou E., Harrington K. J., Cytotoxic therapy of gastroenteropancreatic (GEP) tumors Anticancer Research 2002 22 2 B 1311 1314
29. Syrigou E., Makrilia N., Koti I., Saif M. W., Syrigos K. N., Hypersensitivity reactions to antineoplastic agents: an overview Anti-Cancer Drugs 2009 20 1 1 6
30. Zanotti K. M., Rybicki L. A., Kennedy A. W., Belinson J. L., Webster K. D., Kulp B., Peterson G., Markman M., Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy Journal of Clinical Oncology 2001 19 12 3126 3129
31. Callahan M. B., Lachance J. A., Stone R. L., Kelsey J., Rice L. W., Jazaeri A. A., Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer American Journal of Obstetrics and Gynecology 2007 197 2 199.e1 199.e5
32. Markman M., Kennedy A., Webster K., Elson P., Peterson G., Kulp B., Belinson J., Clinical features of hypersensitivity reactions to carboplatin Journal of Clinical Oncology 1999 17 4 1141 1145
33. Rose P. G., Fusco N., Smrekar M., Mossbruger K., Rodriguez M., Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity Gynecologic Oncology 2003 89 3 429 433
34. O'Cearbhaill R., Zhou Q., Iasonos A., Hensley M. L., Tew W. P., Aghajanian C., Spriggs D. R., Lichtman S. M., Sabbatini P. J., The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment Gynecologic Oncology 2010 116 3 326 331
35. Kosmidis P. A., Kalofonos H. P., Christodoulou C., Syrigos K., Makatsoris T., Skarlos D., Bakogiannis C., Nicolaides C., Bafaloukos D., Bamias A., Samantas E., Xiros N., Boukovinas I., Fountzilas G., Dimopoulos M. A., Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group Annals of Oncology 2008 19 1 115 122
36. Karapanagiotou E. M., Charpidou A., Tzannou I., Dilana K., Kotteas E., Tourkantonis I., Kosmas E., Provata A., Syrigos K., A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer Medical Oncology 2008 25 3 303 308
37. Georgoulias V., Ardavanis A., Agelidou A., Agelidou M., Chandrinos V., Tsaroucha E., Toumbis M., Kouroussis C., Syrigos K., Polyzos A., Samaras N., Papakotoulas P., Christofilakis C., Ziras N., Alegakis A., Docetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small-cell lung cancer: a randomized, multicenter phase III trial Journal of Clinical Oncology 2004 22 13 2602 2609
38. Kook H., Kim K. M., Choi S. H., Choi B. S., Kim H. J., Chung S. Y., Choi S. J. N., Hwang T. J., Life-threatening carboplatin hypersensitivity during conditioning for autologous PBSC transplantation: successful rechallenge after desensitization Bone Marrow Transplantation 1998 21 7 727 729
39. Sliesoraitis S., Chikhale P. J., Carboplatin hypersensitivity International Journal of Gynecological Cancer 2005 15 1 13 18
40. Sugimoto H., Iwamoto T., Murashima Y., Tabata T., Sagawa N., Okuda M., Risk factors contributing to the development of carboplatin-related delayed hypersensitivity reactions in Japanese patients with gynecologic cancers. Cancer Chemotherapy and Pharmacology, 2010. In press
41. Hoekstra A. V., Hurteau J. A., Kirschner C. V., Rodriguez G. C., The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer Gynecologic Oncology 2009 115 3 377 381
42. Morgan J. S., Adams M., Mason M. D., Hypersensitivity reactions to carboplatin given to patients with relapsed ovarian carcinoma European Journal of Cancer A 1994 30 8 1205 1206
43. Koren C., Yerushalmi R., Katz A., Malik H., Sulkes A., Fenig E., Hypersensitivity reaction to cisplatin during chemoradiation therapy for gynecologic malignancy American Journal of Clinical Oncology 2002 25 6 625 626
44. Bautista M. A., Stevens W. T., Chen C.-S., Curtis B. R., Aster R. H., Hsueh C.-T., Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature Journal of Hematology and Oncology 2010 3, article 12
45. Shibata Y., Ariyama H., Baba E., Takii Y., Esaki T., Mitsugi K., Tsuchiya T., Kusaba H., Akashi K., Nakano S., Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan International Journal of Clinical Oncology 2009 14 5 397 401
46. Kim B. H., Bradley T., Tai J., Budman D. R., Hypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature review Oncology 2009 76 4 231 238
47. Shlebak A. A., Clark P. I., Green J. A., Hypersensitivity and cross-reactivity to cisplatin and analogues Cancer Chemotherapy and Pharmacology 1995 35 4 349 351
48. Tournigand C., Maindrault-Goebel F., Louvet C., de Gramont A., Krulik M., Severe anaphylactic reactions to oxaliplatin European Journal of Cancer 1998 34 8 1297 1298
49. Medioni J., Coulon M. A., Morere J. F., Hennebelle F., Piperno-Neumann S., Breau J. L., Anaphylaxis after oxaliplatin Annals of Oncology 1999 10 5 610
50. Abe A., Ikawa H., Ikawa S., Desensitization treatment with cisplatin after carboplatin hypersensitivity reaction in gynecologic cancer Journal of Medical Investigation 2010 57 1-2 163 167
51. Gomez R., Harter P., Lck H.-J., Traut A., Kommoss S., Kandel M., Du Bois A., Carboplatin hypersensitivity does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study International Journal of Gynecological Cancer 2009 19 7 1284 1287
52. Hesterberg P. E., Banerji A., Oren E., Penson R. T., Krasner C. N., Seiden M. V., Wong J. T., Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management Journal of Allergy and Clinical Immunology 2009 123 6 1262 1267
53. Castells M. C., Tennant N. M., Sloane D. E., Ida Hsu F., Barrett N. A., Hong D. I., Laidlaw T. M., Legere H. J., Nallamshetty S. N., Palis R. I., Rao J. J., Berlin S. T., Campos S. M., Matulonis U. A., Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases Journal of Allergy and Clinical Immunology 2008 122 3 574 580
54. Confino-Cohen R., Fishman A., Altaras M., Goldberg A., Successful carboplatin desensitization in patients with proven carboplatin allergy Cancer 2005 104 3 640 643
55. Lee C.-W., Matulonis U. A., Castells M. C., Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses Gynecologic Oncology 2005 99 2 393 399
56. Markman M., Hsieh F., Zanotti K., Webster K., Peterson G., Kulp B., Spicel A., Belinson J., Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin- hypersensitivity reactions Journal of Cancer Research and Clinical Oncology 2004 130 1 25 28
57. Jones R., Ryan M., Friedlander M., Carboplatin hypersensitivity reactions: re-treatment with cisplatin desensitisation Gynecologic Oncology 2003 89 1 112 115
58. Syrigou E. I., Karapanagiotou E. M., Alamara C. V., Boura P. G., Saif M. W., Syrigos K. N., Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol Clinical Colorectal Cancer 2009 8 2 106 109
59. Nozawa H., Muto Y., Yamada Y., Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer Clinical Therapeutics 2008 30 6 1160 1165
60. Wrzesinski S. H., McGurk M. L., Donovan C. T., Ferencz T. M., Saif M. W., Successful desensitization to oxaliplatin with incorporation of calcium gluconate and magnesium sulfate Anti-Cancer Drugs 2007 18 6 721 724
61. Edmondson D. A., Gruling B. J., Urmanski A. M., Wong S. J., Levy M. B., Oxaliplatin hypersensitivity: case report and successful repeat desensitization American Journal of Therapeutics 2007 14 1 116 118
62. Herrero T., Tornero P., Infante S., Fuentes V., Snchez M. N., De Barrio M., Baeza M. L., Diagnosis and management of hypersensitivity reactions caused by oxaliplatin Journal of Investigational Allergology and Clinical Immunology 2006 16 5 327 330
63. Mis L., Fernando N. H., Hurwitz H. I., Morse M. A., Successful desensitization to oxaliplatin Annals of Pharmacotherapy 2005 39 5 966 969
64. Lim K.-H., Huang M.-J., Lin H.-C., Su Y.-W., Chang Y.-F., Lin J., Chang M.-C., Hsieh R.-K., Hypersensitivity reactions to oxaliplatin: a case report and the success of a continuous infusional desensitization schedule Anti-Cancer Drugs 2004 15 6 605 607
65. Gammon D., Bhargava P., McCormick M. J., Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol Oncologist 2004 9 5 546 549
66. Schll B., Kornek G. V., Scheithauer W., Idiosyncratic reaction after oxaliplatin: circumvention by use of a continuous infusional administration schedule Annals of Oncology 2001 12 11 1653 1654
67. Newman Taylor A. J., Cullinan P., Lympany P. A., Harris J. M., Dowdeswell R. J., Du Bois R. M., Interaction of HLA phenotype and exposure intensity in sensitization to complex platinum salts American Journal of Respiratory and Critical Care Medicine 1999 160 2 435 438
68. Markman M., Zanotti K., Kulp B., Peterson G., Markman M., Relationship between a history of systemic allergic reactions and risk of subsequent carboplatin hypersensitivity Gynecologic Oncology 2003 89 3 514 516
69. Gadducci A., Tana R., Teti G., Zanca G., Fanucchi A., Genazzani A. R., Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer International Journal of Gynecological Cancer 2008 18 4 615 620
70. Navo M., Kunthur A., Badell M. L., Coffer L. W. II, Markman M., Brown J., Smith J. A., Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients Gynecologic Oncology 2006 103 2 608 613
71. Schwartz J. R., Bandera C., Bradley A., Brard L., Legare R., Granai C. O., Dizon D. S., Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants' Hospital Gynecologic Oncology 2007 105 1 81 83
72. Bamias A., Syrigos K., Fountzilas G., Tzamakou E., Soulti K., Karavasilis V., Alamanos Y., Christodoulou C., Pavlidis N., Intensified bimonthly cisplatin with bolus 5-fluorouracil, continuous 5-fluorouracil and high-dose leucovorin (LV5FU2) in patients with advanced gastrointestinal carcinomas: a phase I dose-finding and pharmacokinetic study American Journal of Clinical Oncology 2004 27 5 465 471
73. Ichikawa Y., Goto A., Hirokawa S., Kijima M., Ishikawa T., Chishima T., Suwa H., Yamamoto H., Yamagishi S., Osada S., Ota M., Fuj S. II, Allergic reactions to oxaliplatin in a single Institute in Japan Japanese Journal of Clinical Oncology 2009 39 9 616 620
74. Pujade-Lauraine E., Wagner U., Aavall-Lundqvist E., Gebski V., Heywood M., Vasey P. A., Volgger B., Vergote I., Pignata S., Ferrero A., Sehouli J., Lortholary A., Kristensen G., Jackisch C., Joly F., Brown C., Le Fur N., du Bois A., Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse Journal of Clinical Oncology 2010 28 20 3323 3329
75. Markman M., Moon J., Wilczynski S., Lopez A. M., Rowland K. M. Jr., Michelin D. P., Lanzotti V. J., Anderson G. L., Alberts D. S., Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: final survival results of a SWOG (S0200) phase 3 randomized trial Gynecologic Oncology 2010 116 3 323 325
76. Shepherd G. M., Hypersensitivity reactions to chemotherapeutic drugs Clinical Reviews in Allergy and Immunology 2003 24 3 253 262
77. Syrigou E., Syrigos K., Saif M. W., Hypersensitivity reactions to oxaliplatin and other antineoplastic agents Current Allergy and Asthma Reports 2008 8 1 56 62
78. Goldberg A., Confino-Cohen R., Fishman A., Beyth Y., Altaras M., A modified, prolonged desensitization protocol in carboplatin allergy Journal of Allergy and Clinical Immunology 1996 98 4 841 843
79. Enrique E., Malek T., Castell J. V., de Mateo J. A., Usefulness of skin testing with platinum salts to demonstrate lack of cross-reactivity between carboplatin and cisplatin Annals of Allergy, Asthma and Immunology 2008 100 1 86
80. Cromwell O., Pepys J., Parish W. E., Hughes E. G., Specific IgE antibodies to platinum salts in sensitized workers Clinical Allergy 1979 9 2 109 117
81. Santini D., Tonini G., Salerno A., Vincenzi B., Patti G., Battistoni F., Dicuonzo G., Labianca R., Idiosyncratic reaction after oxaliplatin infusion Annals of Oncology 2001 12 1 132 133
82. Lee M.-Y., Yang M.-H., Liu J.-H., Yen C.-C., Lin P.-C., Teng H.-W., Wang W.-S., Chiou T.-J., Chen P.-M., Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication Supportive Care in Cancer 2007 15 1 89 93
83. Garufi C., Vaglio S., Brienza S., Conti L., D'Attino R. M., Girelli G., Terzoli E., Immunohemolytic anemia following oxaliplatin administration Annals of Oncology 2000 11 4 497
84. Thomas R. R., Quinn M. G., Schuler B., Grem J. L., Hypersensitivity and idiosyncratic reactions to oxaliplatin Cancer 2003 97 9 2301 2307
85. de Vries R. S., Mattijssen E. J., van Sorge A. A., Serious delayed hypersensitivity reaction to oxaliplatin Annals of Oncology 2006 17 11 1723 1724
86. Morgan M., Bowers D. C., Gruchalla R. S., Khan D. A., Safety and efficacy of repeated monthly carboplatin desensitization Journal of Allergy and Clinical Immunology 2004 114 4 974 975
87. Vekris A., Meynard D., Haaz M.-C., Bayssas M., Bonnet J., Robert J., Molecular determinants of the cytotoxicity of platinum compounds: the contribution of in silico research Cancer Research 2004 64 1 356 362
88. Greene D. P., Ferriss J. S., Jazaeri A. A., Cisplatin administration following carboplatin desensitization failure in primary peritoneal cancer: a brief report Cancer Chemotherapy and Pharmacology 2010 66 2 265 267
89. Dizon D. S., Sabbatini P. J., Aghajanian C., Hensley M. L., Spriggs D. R., Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy Gynecologic Oncology 2002 84 3 378 382
90. Zweizig S., Roman L. D., Muderspach L. I., Death from anaphylaxis to cisplatin: a case report Gynecologic Oncology 1994 53 1 121 122
91. Maindrault-Goebel F., Andr T., Tournigand C., Louvet C., Perez-Staub N., Zeghib N., De Gramont A., Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients European Journal of Cancer 2005 41 15 2262 2267
92. Potenza S., Nasti G., Alessandro O., Filippelli A., Rossi F., Capuano A., Severe respiratory symptoms to oxaliplatin infusion: a case report of delayed hypersensitivity reaction Investigational New Drugs 2010 28 2 185 186
93. Saif M. W., Roy S., Ledbetter L., Madison J., Syrigos K., Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction World Journal of Gastroenterology 2007 13 39 5277 5281
94. Saif M. W., Syrigos K. I., Hotchkiss S., Shanley J., Grasso J., Ferencz T. M., Syrigos K., Shah M. M., Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancer Cancer Chemotherapy and Pharmacology 2009 65 1 107 112
95. Montiel Herrera J. M., Gngora-Melendez M. A., Pineda-Maldonado M. L., Carboplatin hypersensitivity and desensitization in an infant Therapeutic Drug Monitoring 2010 32 4 525 528
96. Markman M., Hypersensitivity reactions to carboplatin Gynecologic Oncology 2002 84 2 353 354
97. Polyzos A., Tsavaris N., Kosmas C., Arnaouti T., Kalahanis N., Tsigris C., Giannopoulos A., Karatzas G., Giannikos L., Sfikakis P. P., Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience Oncology 2001 61 2 129 133
98. Porzio G., Marchetti P., Paris I., Narducci F., Ricevuto E., Ficorella C., Hypersensitivity reaction to carboplatin: successful resolution by replacement with cisplatin European Journal of Gynaecological Oncology 2002 23 4 335 336
99. Kandel M. J., Loehr A., Harter P., Traut A., Gnauert K., Du Bois A., Cisplatinum rechallenge in relapsed ovarian cancer patients with platinum reinduction therapy and carboplatin hypersensitivity International Journal of Gynecological Cancer 2005 15 5 780 784
100. Elligers K. T., Davies M., Sanchis D., Ferencz T., Saif M. W., Rechallenge with cisplatin in a patient with pancreatic cancer who developed a hypersensitivity reaction to oxaliplatin. Is skin test useful in this setting? Journal of the Pancreas 2008 9 2 197 202
101. Ottaiano A., Tambaro R., Greggi S., Prato R., Di Maio M., Esposito G., Scala F., Barletta E., Losito S., De Vivo R., Iaffaioli VR., Pignata S., Safety of cisplatin after severe hypersensitivity reactions to carboplatin in patients with recurrent ovarian carcinoma Anticancer Research 2003 23 4 3465 3468
102. Robinson J. B., Singh D., Bodurka-Bevers D. C., Wharton J. T., Gershenson D. M., Wolf J. K., Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies Gynecologic Oncology 2001 82 3 550 558
103. Markman M., Zanotti K., Peterson G., Kulp B., Webster K., Belinson J., Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity Journal of Clinical Oncology 2003 21 24 4611 4614
104. Leguy-Seguin V., Jolimoy G., Coudert B., Pernot C., Dalac S., Vabres P., Collet E., Diagnostic and predictive value of skin testing in platinum salt hypersensitivity Journal of Allergy and Clinical Immunology 2007 119 3 726 730
105. Syrigou E., Makrilia N., Vassias A., Nikolaidis I., Xyla V., Manolopoulos L., Syrigos K., Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful? Anti-Cancer Drugs 2010 21 3 333 338
106. Gowda A., Goel R., Berdzik J., Leichman C. G., Javle M., Hypersensitivity reactions to oxaliplatin: incidence and management Oncology 2004 18 13 1671 1675
107. Brandi G., Pantaleo M. A., Galli C., Falcone A., Antonuzzo A., Mordenti P., Di Marco M. C., Biasco G., Hypersensitivity reactions related to oxaliplatin (OHP) British Journal of Cancer 2003 89 3 477 481
108. Bhargava P., Gammon D., McCormick M. J., Hypersensitivity and idiosyncratic reactions to oxaliplatin Cancer 2004 100 1 211 212
109. Siu S. W. K., Chan R. T. T., Au G. K. H., Hypersensitivity reactions to oxaliplatin: experience in a single institute Annals of Oncology 2006 17 2 259 261
110. Meyer L., Zuberbier T., Worm M., Oettle H., Riess H., Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule Journal of Clinical Oncology 2002 20 4 1146 1147
111. Lvi F., Zidani R., Misset J.-L., Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer Lancet 1997 350 9079 681 686
112. Garufi C., Cristaudo A., Vanni B., Bria E., Aschelter A. M., Santucci B., Terzoli E., Skin testing and hypersensitivity reactions to oxaliplatin Annals of Oncology 2003 14 3 497 498